Cucumber, Vitamin K, and Bone Health

Table of Contents

1. What Vitamin K Actually Does
2. How Much Vitamin K Is in a Cucumber
3. The Peel Is the Vitamin K
4. Absorption: Why Vegetable K1 Needs Fat
5. The Bone Mechanism: Osteocalcin
6. What the Bone Trials Actually Showed
7. Matrix Gla Protein and the Artery Story
8. If You Take Warfarin: Consistency, Not Avoidance
9. Silicon: The Other Claim About Cucumber Skin
10. An Honest Summary
11. Practical: Getting the Vitamin K Out of a Cucumber
12. Key Research Papers
13. Connections
14. Featured Videos

What Vitamin K Actually Does

Vitamin K is a fat-soluble vitamin that exists in two dietary forms. Phylloquinone (K1) is made by plants, sits in the chloroplasts of green tissue, and is by a wide margin the dominant form in the human diet. Menaquinones (K2) are made by bacteria, appear in fermented foods and in some animal foods, and account for a smaller share of intake. Cucumber supplies K1.

Its job is unusual and specific. Vitamin K is the essential cofactor for an enzyme, gamma-glutamyl carboxylase, that performs a single chemical modification: it converts particular glutamate residues in certain proteins into gamma-carboxyglutamate. That modification gives the protein a claw that grips calcium ions. Without vitamin K the modification does not happen, and the protein circulates in an undercarboxylated form — present, measurable, and functionally inert.

Roughly a dozen human proteins depend on this. The best known are the clotting factors made in the liver — factors II, VII, IX and X, plus proteins C and S — which is why vitamin K deficiency shows up first as bleeding, and why warfarin, which blocks the recycling of vitamin K, works as an anticoagulant.

The interesting part, and the subject of Sarah Booth's widely cited review of vitamin K's roles beyond coagulation, is that the same machinery operates outside the liver. Two of the extrahepatic vitamin K-dependent proteins matter here: osteocalcin, made by bone-forming cells, and matrix Gla protein, made in cartilage and the walls of blood vessels. Both need vitamin K to be carboxylated, and both are involved in where calcium ends up in the body. That is the whole basis for the bone and artery interest, and it is a genuinely sound mechanism — which makes the disappointing trial results discussed further down all the more instructive.

Back to Table of Contents

How Much Vitamin K Is in a Cucumber

Raw cucumber with the peel carries in the region of sixteen micrograms of phylloquinone per hundred grams. That places it in the middle of the vegetable range — well below the dark leafy greens, comfortably above most fruit, roots and alliums. Damon, Zhang, Haytowitz and Booth's analysis of phylloquinone across vegetables, work done to underpin the composition databases, shows the same broad pattern that any cook would guess: green and leafy is high, pale and non-leafy is low, and the pigment tracks the vitamin because both live in the chloroplast.

Converted into portions:

• A cup of unpeeled slices (about a hundred and twenty grams) supplies roughly twenty micrograms.
• A whole medium unpeeled cucumber (about three hundred grams) supplies roughly fifty micrograms.
• A large English cucumber eaten across a day can approach seventy.

Set that against adequate intakes of about ninety micrograms a day for adult women and a hundred and twenty for adult men in the United States figures, with European values somewhat lower. A whole unpeeled cucumber therefore covers something in the region of forty to fifty-five percent of a woman's adequate intake and around forty percent of a man's. For a vegetable that is ninety-five percent water, that is a genuinely respectable showing, and it is the one nutrient claim about cucumber that does not need any hedging.

The broader context, from Booth and Suttie's work on dietary intake and adequacy of vitamin K, is that ordinary intakes vary enormously between individuals because they are dominated by a small number of leafy-green foods eaten irregularly. A person who eats a large salad most days sits comfortably above the adequate intake; a person who does not may spend much of the week well below it. Cucumber is useful precisely because it is one of the salad foods that people eat willingly and often.

Back to Table of Contents

The Peel Is the Vitamin K

Phylloquinone lives in chloroplasts, chloroplasts are where the chlorophyll is, and in a cucumber the chlorophyll is almost entirely in the dark green skin. The flesh is pale for the same reason it is bland: there is very little photosynthetic tissue in it.

The composition data follow directly. Peeled raw cucumber carries roughly half the vitamin K of unpeeled cucumber per hundred grams — the drop is that steep, from a middling vegetable figure to a distinctly low one. Peeling also removes most of the fibre and the carotenoids, and it takes away the crunch that makes cucumber satisfying.

This is why the reflex advice to peel cucumbers deserves resisting. There are three usual reasons given, and each has a better answer:

• "The skin is waxed." Slicing cucumbers sold loose often are. The coating is a food-grade wax, and a scrub under running water removes the bulk of it. English and Persian cucumbers are usually not waxed at all — the long ones are shrink-wrapped instead, which does the same job.
• "The skin is bitter." Occasionally true, and it is a real signal rather than a nuisance — cucurbitacins concentrate under the peel and at the stem end. If the skin tastes bitter, taste the flesh; if that is bitter too, discard the cucumber. This is covered fully in Cucurbitacins and Safety.
• "The skin is tough." A cultivar problem, not a cucumber problem. Persian, Lebanese and English types have thin, tender skins bred for eating.

A reasonable compromise, if you dislike the texture, is to peel in stripes — run a peeler down the cucumber leaving alternating bands of skin. You keep roughly half the vitamin K and fibre, and the mouthfeel changes completely.

Back to Table of Contents

Absorption: Why Vegetable K1 Needs Fat

Getting vitamin K onto the plate is only half the problem. Phylloquinone in a raw vegetable is tightly bound within the chloroplast membrane, and that matrix is difficult to digest. Absorption of K1 from vegetables is considerably lower than from an oil-based supplement — the figure quoted in the nutrition literature is usually in the region of a tenth to a fifth of the dose, against far higher fractions from purified forms dissolved in fat.

Two levers improve it, and both are ordinary kitchen practice:

1. Eat fat in the same meal. Phylloquinone is fat-soluble and is packaged into chylomicrons for absorption alongside dietary lipid. A cucumber salad dressed with olive oil, or eaten with yoghurt, avocado, tahini, nuts or oily fish, delivers substantially more absorbed vitamin K than the same cucumber eaten plain. This is one of the clearest and least-known reasons to dress a salad rather than eat it naked.
2. Break up the tissue. Chopping, slicing thinly and chewing thoroughly all disrupt the chloroplast membranes and improve release. Cooking does the same for greens; cucumber is nearly always eaten raw, so the knife is doing that work.

Shea and Booth's review of how vitamin K status is evaluated in population studies is worth knowing about here, because it explains why this field is harder than it looks. There is no simple, universally agreed blood test for vitamin K status. Circulating phylloquinone reflects recent intake and swings with the last meal. Undercarboxylated osteocalcin is a functional marker but is influenced by other things. The proportion of undercarboxylated matrix Gla protein is informative for vascular questions. Different studies use different markers, which is one reason the literature is less tidy than the mechanism suggests it should be.

Back to Table of Contents

The Bone Mechanism: Osteocalcin

Osteocalcin is one of the most abundant non-collagen proteins in bone, produced by osteoblasts — the cells that build bone. When it is carboxylated, its three gamma-carboxyglutamate residues bind calcium and let the protein attach to the mineral crystal of bone. When vitamin K is short, more of the osteocalcin produced circulates undercarboxylated.

The observational epidemiology fitted this neatly. Higher circulating undercarboxylated osteocalcin has been associated with lower bone mineral density and higher fracture risk in several cohorts. Higher dietary vitamin K intake has been associated with lower fracture risk. Hao and colleagues' meta-analysis of vitamin K intake and fracture risk pooled that observational literature and found the association held across studies.

It is a genuinely attractive story: a specific protein, a specific chemical modification, a specific nutrient, and consistent population data. The trials are where it becomes complicated, and it is worth reading that next section carefully, because it is a good lesson in how nutrition evidence works.

Back to Table of Contents

What the Bone Trials Actually Showed

Two well-conducted randomised controlled trials tested whether supplementing vitamin K improves bone outcomes, and neither delivered what the observational data had promised.

Booth and colleagues randomised older men and women to a daily phylloquinone supplement or placebo, on top of calcium and vitamin D, and followed bone mineral density over three years. The supplement did what it was supposed to biochemically — circulating phylloquinone rose and undercarboxylated osteocalcin fell — but bone mineral density at the hip and spine did not differ from placebo.

The ECKO trial, reported by Cheung and colleagues, randomised postmenopausal women with osteopenia to a substantially larger daily dose of vitamin K1 or placebo and followed them for two years, with an extension. Again, bone mineral density did not differ between groups. The authors reported fewer fractures and fewer cancers in the treated group, but these were secondary outcomes on small numbers, and the trial was not designed or powered to answer them — the honest reading is that they are hypothesis-generating, not evidence of benefit.

So what should a reader take from this?

• The carboxylation effect is real; the bone-density effect was not found. Supplementing vitamin K reliably changes the biochemical marker. In these trials it did not change the outcome that matters.
• Observational associations may be tracking something else. People with high vitamin K intakes are people who eat a lot of green vegetables, and they differ from low-intake people in dozens of ways — overall diet quality, physical activity, smoking, body weight, socioeconomic position. Green-vegetable eating may be a marker for a life that protects bone rather than the protective agent itself.
• Bone mineral density is not the same as fracture. It is possible for a nutrient to affect bone quality — the organisation of the mineral and matrix — without moving a density scan. This is a live argument, not a settled one, and it is the reason the field has not closed the question.
• A trial of a supplement is not a trial of a food. Cucumber does not deliver isolated phylloquinone; it delivers phylloquinone alongside potassium, fibre, water and the displacement of denser food. Those effects were not on test.

The defensible position is therefore modest, and this page will not overstate it: eating vitamin K-containing vegetables is part of an eating pattern associated with better bone health, and vitamin K is unambiguously required for normal osteocalcin function — but taking vitamin K to build bone density is not supported by the randomised evidence.

Back to Table of Contents

Matrix Gla Protein and the Artery Story

The other extrahepatic vitamin K-dependent protein has, over the last two decades, become the more scientifically interesting one.

Matrix Gla protein is made in vascular smooth muscle and cartilage, and its function is inhibitory: carboxylated matrix Gla protein binds calcium and actively prevents it from being deposited in soft tissue. The evidence for this is unusually strong, because it comes from a genetic experiment. Animals lacking the gene develop rapid, severe calcification of the arteries, and humans with Keutel syndrome, a rare inherited deficiency of the protein, show abnormal cartilage and soft-tissue calcification. Removing the protein reliably causes calcification, which is about as clear a demonstration of function as biology offers.

Because carboxylation of matrix Gla protein requires vitamin K, undercarboxylated matrix Gla protein has become a marker of interest in vascular disease. Roumeliotis and colleagues review this in chronic kidney disease, a population in which vascular calcification is common, severe and strongly linked to mortality, and in which vitamin K status is frequently poor.

Where the evidence stands, honestly:

• The mechanism is well established, including through genetic evidence.
• Higher circulating undercarboxylated matrix Gla protein is associated with more calcification and worse outcomes in several observational studies.
• Trials of vitamin K supplementation aimed at slowing vascular calcification have been conducted mainly in kidney disease and in warfarin users, and the results have been mixed rather than conclusive. This remains an open research question.
• None of this has been tested as a food intervention, and no trial has examined cucumber or any single vegetable.

It is a mechanism worth knowing about, and a reason to take vitamin K seriously as a nutrient rather than dismissing it as "the clotting vitamin". It is not, at present, a reason to make health claims about a salad vegetable.

Back to Table of Contents

If You Take Warfarin: Consistency, Not Avoidance

This is the section that matters most in practice, because the advice most people are given is subtly wrong in a way that makes their treatment harder.

Warfarin works by blocking vitamin K epoxide reductase, the enzyme that regenerates vitamin K after it has been used. With less recycled vitamin K available, the clotting factors are undercarboxylated, and the blood clots more slowly. The dose is titrated against the INR, a measure of that slowing.

Because dietary vitamin K opposes the drug, patients are frequently told to "avoid vitamin K foods" — which usually means avoiding green vegetables. That advice is outdated and counterproductive for two reasons.

First, it makes control worse, not better. Leblanc and colleagues studied long-term warfarin patients and found that higher vitamin K intake was associated with better INR control and a reduced need for INR testing. The mechanism is intuitive once stated: a person on a very low vitamin K intake has no buffer, so any variation — one unusual salad, one week of different eating — swings the INR sharply. A person on a steady, moderately high intake has a stable baseline against which the warfarin dose can be set, and ordinary day-to-day variation moves them very little.

Second, it costs the patient the vegetables. Warfarin patients are, by definition, people with cardiovascular or thromboembolic disease, which is exactly the group for whom a vegetable-rich diet matters most. Telling them to avoid greens trades a manageable pharmacological problem for a dietary one.

The correct advice, and the advice modern anticoagulation clinics give, is consistency. Eat vitamin K-containing foods, including cucumber, in a roughly steady pattern week to week. Let the dose be set against your normal diet. Avoid sudden large changes in either direction — a fortnight of daily kale after months of none, or a fortnight of no vegetables at all, will both move the INR. If you do plan a substantial change to your diet, tell the clinic so they can check the INR through the transition.

Cucumber is a mild example of all this — fifty micrograms is not a dramatic dose — but the principle is the same, and it is worth knowing that a daily cucumber is not something to be frightened of. It is something to be consistent about.

Back to Table of Contents

Silicon: The Other Claim About Cucumber Skin

Cucumber turns up constantly on lists of "silica-rich foods" for hair, skin, nails and bone. This deserves an honest treatment rather than either endorsement or dismissal.

What is solid: silicon is present in the human body, is concentrated in connective tissue, and appears to have a role in bone and collagen formation. Jugdaohsingh and colleagues, analysing dietary silicon intake in the Framingham Offspring cohort, found a positive association between silicon intake and bone mineral density at the hip in men and in premenopausal women — an association of a size comparable to that seen for better-known bone nutrients. That is a real and well-conducted observational finding.

What is weaker, and where the internet overreaches:

• Silicon has no established requirement. It is not classified as an essential nutrient for humans, there is no recommended intake, and no deficiency syndrome has been defined.
• The main dietary sources are not vegetables. In the Framingham analysis and in other intake studies, the dominant contributors to silicon intake in Western diets are grains and beer, with drinking water contributing in soluble form. Cucumber is not among the leading sources.
• Cucumber's silicon content is not well quantified. Silicon is absent from most standard food composition tables, including the routine entries people quote. The claim that cucumber is a rich source is largely repeated from secondary sources rather than measured.
• Bioavailability varies enormously. Silicon must be in a soluble form (orthosilicic acid) to be absorbed; much plant silicon is present as insoluble phytoliths and passes straight through. The presence of silicon in a food does not mean the silicon reaches you.
• No trial has shown that eating cucumber improves hair, skin, nails or bone. None has been done.

The fair summary: silicon is a legitimate research area with real observational support for bone, cucumber probably contributes some, and no one should eat cucumber for its silicon. If the silicon story turns out well, cucumber will have been a minor contributor to a diet that was already doing the work.

Back to Table of Contents

An Honest Summary

Assembling the whole picture:

• Cucumber is a legitimate, if middling, vitamin K food — around fifty micrograms in a whole unpeeled fruit, which is a substantial fraction of a day's adequate intake for a food that is mostly water.
• Almost all of it is in the peel. Peeling roughly halves it. This is the single actionable fact on the page.
• Fat in the same meal materially improves how much you absorb. Dress the salad.
• Vitamin K is genuinely required for osteocalcin and matrix Gla protein, and undercarboxylation of both is associated with worse bone and vascular outcomes.
• Supplement trials did not improve bone mineral density. Anyone telling you vitamin K builds bone is going beyond the randomised evidence.
• The artery mechanism is strong and the clinical evidence is unfinished. Watch this one; do not bet on it yet.
• On warfarin, be consistent rather than avoidant. Higher, steadier vitamin K intake is associated with better INR control.
• The silica claim is thin. Not false, not established, and not a reason to choose cucumber.

Cucumber does not need to be a superfood to be worth eating daily. It needs to be pleasant, cheap, low in energy, and to carry something real. It is all four.

Back to Table of Contents

Practical: Getting the Vitamin K Out of a Cucumber

• Do not peel by default. Wash and scrub instead. If the skin is tough, choose Persian, Lebanese or English cucumbers, which are bred for thin skins, or peel in stripes to keep half the benefit.
• Dress it with real fat. Olive oil, full-fat yoghurt, avocado, tahini, nuts or seeds — all of them improve phylloquinone absorption and all of them make the cucumber taste better. Whole-food fats, not fat-free dressings.
• Slice thinly and chew. Disrupting plant tissue releases vitamin K from the chloroplast membranes it is bound into.
• Combine it with a proper green. Cucumber is a supporting player. Adding a handful of spinach, rocket, parsley or dill to the same salad multiplies the vitamin K several times over at almost no cost in calories.
• Keep it regular rather than occasional. Vitamin K has no large body store, and blood levels reflect recent intake. A daily moderate intake serves you far better than one enormous salad a week — and if you take warfarin, regularity is the whole point.
• Cucumber and yoghurt is the ideal pairing. Tzatziki, raita, cucumber-yoghurt soup — each combines the peel's vitamin K with the fat that carries it, plus potassium, and each is a dish people finish rather than a health measure they endure.
• Do not count pickles the same way. Brined and vinegar pickles are a different food, with a sodium load that changes the calculation entirely; the fresh fruit is the vitamin K vehicle.

Back to Table of Contents

Key Research Papers

1. Booth SL. Roles for vitamin K beyond coagulation. Annual Review of Nutrition. 2009;29:89–110. — doi:10.1146/annurev-nutr-080508-141217
2. Damon M, Zhang NZ, Haytowitz DB, Booth SL. Phylloquinone (vitamin K1) content of vegetables. Journal of Food Composition and Analysis. 2005;18(8):751–758. — doi:10.1016/j.jfca.2004.07.004
3. Booth SL, Suttie JW. Dietary intake and adequacy of vitamin K. The Journal of Nutrition. 1998;128(5):785–788. — doi:10.1093/jn/128.5.785
4. Shea MK, Booth SL. Concepts and controversies in evaluating vitamin K status in population-based studies. Nutrients. 2016;8(1):8. — doi:10.3390/nu8010008
5. Booth SL, Dallal G, Shea MK, Gundberg C, Peterson JW, Dawson-Hughes B. Effect of vitamin K supplementation on bone loss in elderly men and women. The Journal of Clinical Endocrinology & Metabolism. 2008;93(4):1217–1223. — doi:10.1210/jc.2007-2490
6. Cheung AM, Tile L, Lee Y, et al. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Medicine. 2008;5(10):e196. — doi:10.1371/journal.pmed.0050196
7. Hao G, Zhang B, Gu M, et al. Vitamin K intake and the risk of fractures: a meta-analysis. Medicine. 2017;96(17):e6725. — doi:10.1097/MD.0000000000006725
8. Roumeliotis S, Dounousi E, Salmas M, Eleftheriadis T, Liakopoulos V. Vascular calcification in chronic kidney disease: the role of vitamin K-dependent matrix Gla protein. Frontiers in Medicine. 2020;7:154. — doi:10.3389/fmed.2020.00154
9. Leblanc C, Presse N, Lalonde G, Dumas S, Ferland G. Higher vitamin K intake is associated with better INR control and a decreased need for INR tests in long-term warfarin therapy. Thrombosis Research. 2014;134(1):210–212. — doi:10.1016/j.thromres.2014.04.024
10. Jugdaohsingh R, Tucker KL, Qiao N, Cupples LA, Kiel DP, Powell JJ. Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham Offspring cohort. Journal of Bone and Mineral Research. 2004;19(2):297–307. — doi:10.1359/JBMR.0301225
11. Mukherjee PK, Nema NK, Maity N, Sarkar BK. Phytochemical and therapeutic potential of cucumber. Fitoterapia. 2013;84:227–236. — doi:10.1016/j.fitote.2012.10.003
12. Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346:f1378. — doi:10.1136/bmj.f1378

Live PubMed Searches

1. PubMed: phylloquinone absorption from vegetables
2. PubMed: undercarboxylated osteocalcin and bone
3. PubMed: matrix Gla protein and vascular calcification
4. PubMed: warfarin and dietary vitamin K consistency
5. PubMed: dietary silicon and connective tissue

Back to Table of Contents

Connections

• Cucumber
• Cucumber Benefits Hub
• Hydration and Electrolytes
• Skin and Eyes
• Cucurbitacins and Safety
• Cucumber: History and Origins
• Vitamin K
• Vitamin A
• Calcium
• Silicon
• Magnesium
• Manganese
• Spinach
• Broccoli
• Cabbage
• Yogurt
• Osteoporosis
• Osteoporosis Deep Dive
• Cardiology
• All Food

Back to Table of Contents

Featured Videos